glp-1 colorectal cancer death risk study november 2025 Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through GLP-1 Drugs Linked to Dramatically

Real-world experiences mirror these clinical findings

Wong, H

Is insulin degludec the same as semaglutide

Daily dosing vs three times weekly dosing The question of whether you can reduce from daily to three times per week comes up frequently with sublingual GLP-1 drops

For some individuals, particularly women approaching or in perimenopause, this shift can unmask or worsen androgenic alopecia, a pattern of hair thinning driven by dihydrotestosterone (DHT) sensitivity in genetically predisposed follicles

No, shortness of breath is not listed as a common or characteristic side effect in FDA prescribing information for GLP-1 medications